SAB management updates by IDSA/ESCMID
#ESCMIDGlobal2024
The term “complicated” SAB varies and does not always suggest longer treatment
Solution: low vs. high-risk populations for SAB
How do we risk stratify SAB into the two levels?
Apr 10, 2024 • 32 tweets • 10 min read
A very enlightening talk by Angela Hutner on simple vs complicated UTI definitions
Simplicity wins
Anything that is beyond the bladder = complicated UTI (including prostatitis)
This will be updated in 2024 by both the IDSA and ESCMID
#IDTwitter #IDXposts
IDSA/ESCMID new guidelines:
Apr 17, 2023 • 17 tweets • 7 min read
New drugs against GNB by Ursula Theuretzbacher #ECCMID2023
In Malaysia, we only have Cefta-avi for resistant GNB infections!
We hope @SHIONOGI_JP will include Malaysia in the list of countries for generic cefiderocol- a project by @gardp_amr
@KKMPutrajaya@DrZalihaMustafa
These are the drugs that are recently approved and we have none of these locally
We can only use Fe-troja(n)/Cefiderocol by @SHIONOGI_JP under the compassionate use program, and the drug is flown all the way from Europe
The cost is huge and our patients can rarely afford it
Apr 16, 2023 • 29 tweets • 11 min read
Fairytales or reality, checking some eminence paradigms for treatment of severe infections
#ECCMID2023
Kill fast! These infections must be treated with a "bactericidal" antibiotic
Beatrice Grabein, Germany
Evolution of CM/ID Specialties by Dr. Rama #ECCMID2023
He talked about his evolution when he came back from the US and the UK
He needed to learn about the cultures in India
This includes antibiotics as a one-size-fits-all remedy
He captured the issues of empiric therapies - one empiric regimen after another.
Apr 15, 2023 • 14 tweets • 4 min read
Tricks and tips for the infectious diseases consultant by Esther CALBO, Spain at #ECCMID2023
Risk of death for ID physicians from "womb to tomb."
Our role is essential (ID consult can reduce the risk of death)
However, we must know how to sell our importance to the hospital suite
Apr 15, 2023 • 7 tweets • 3 min read
Does AMR increase the risk for bacteremia recurrence?
Session: Impact of antimicrobial resistance on the risk of recurrence after community-onset bacteremia
Speaker: Salam Abarra
Risk factors for persistent bacteremia in patients with GNB BSI: an SR with meta-analysis
Do you do a FUBC in GNB patients? @alif82 (something that might interest you)
QnA: How freq was the FUBC in these studies?
Variable ways of FUBC in all the included studies